KEYNOTE-042 and the role for single agent pembrolizumab in patients with PD-L1 tumor proportion score 1-49%

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)S1963-S1965
JournalJournal of Thoracic Disease
Volume11
DOIs
StatePublished - Jan 1 2019

Cite this